The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of HE4 in predicting surgical outcome in recurrent ovarian cancer (ROC).
E. I. Braicu
No relevant relationships to disclose
C. Fotopoulou
No relevant relationships to disclose
R. Richter
No relevant relationships to disclose
R. Chekerov
No relevant relationships to disclose
K. Pietzner
No relevant relationships to disclose
C. Hall
Employment or Leadership Position - Fujirebio Diagnostics (U)
W. Lichtenegger
No relevant relationships to disclose
J. Sehouli
No relevant relationships to disclose